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Abstract— Introduction: The oxyhemoglobin 
dissociation curve describes the relationship between the 
partial pressure of oxygen and the percent of hemoglobin 
saturated with oxygen.  This relationship is a sigmoidal 
shaped curve.    The oxyhemoglobin dissociation curve  
varies from patient to patient.  If patient variability could 
be determined patient specific oxygen flow rates could be 
delivered.  We have developed a model for characterizing 
patient specific variations in SpO2.  Our model predicts 
saturation by generating a patient-specific oxyhemoglobin 
dissociation curve.  The purpose of this study was to 
determine the effectiveness of our patient-specific model.  
Methods: We Probed SpO2 level at various oxygen 
inhalation amounts to provide input to our model.  We 
linearized the relationship between SpO2 and EtO2 for 
each participant.  We then fit a line to those linearized 
data points.  We used model fit error techniques to show 
the ability of the model to fit volunteer and patient SpO2.  
Fit results were generated by using the fitted patient 
specific curve shift to estimate oxygen concentrations.  Fit 
errors were used to assess the model’s ability to fit SpO2 
and to make an accurate patient specific oxyhemoglobin 
dissociation curve .  Results: Thirty subjects participated 
in our volunteer study.  The nominal average line is quite 
close to the standard curve.  The cumulative density plot of 
the model fit error for the entire data set in our volunteer 
study and the average for each volunteer had greater 
accuracy than the standard fit.  Sixty patients participated 
in our clinical trial.  The nominal average line is quite 
different than the standard curve.  The cumulative density 
plot of the model fit error for the entire data set in our 
clinical study and the average for each patient both had 
greater accuracy than the standard fit.  Discussion: This 
study has shown that our model is able to fit patient 
saturation values with higher accuracy compared to using 
the standard oxyhemoglobin dissociation curve.  We have 
also shown that the variability of the ODC from patient to 
patient is quite large, making predicting patient saturation 
quite difficult.  We have developed and tested a model for 
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fitting the oxyhemoglobin dissociation curve to patients.  
We have shown improved fit when compared to the 
standard oxyhemoglobin dissociation curve.  This model 
could potentially be used to predict time to desaturation 
specific to a patient. 
Index Terms—Oxyhemoglobin Dissociation, Model Fit 
Validation, Patient-specific Modeling 
I. INTRODUCTION 
he oxyhemoglobin dissociation curve (ODC) 
describes the relationship between the partial 
pressure of oxygen and the percent of hemoglobin 
saturated with oxygen [1].  This relationship is a 
sigmoidal shaped curve that typically reaches a 
plateau at a partial pressure of oxygen (PO2) of 70 
mm Hg and then slowly approaches 100% 
saturation [2].  Below 70 mmHg the ODC has a 
sharp decline (Figure 1).  The plateau of the ODC 
means for that portion of the curve large changes in 
PO2 result in small changes in saturation while the 
sharp decline means that small changes in PO2 result 
in drastic changes in saturation, which can be life 
threatening (Figure 2). 
Monitored anesthesia care can result in drug-
induced respiratory depression and subsequent 
desaturation [3].  For this reason, supplemental 
oxygen is often given to increase PO2.  However, 
too much supplemental oxygen can delay the time 
until respiratory depression is noticed.  Recognition 
that high levels of oxygen may impair detection of 
hypoventilation by pulse oximetry has led to the 
recommendation by some that oxygen should not be 
administered during monitored anesthesia care [4-
6].  While this may be effective, low levels of 
oxygen can lead to frequent hypoxic episodes and 
decrease the alveolar oxygen reserve available at 
the time of a patient emergency.   
Oxygen saturation is measured using pulse 
oximetry.  Pulse oximeters determine oxygen 
saturation based on differences in light absorption 
in tissues and both venous and capillary blood [2].  
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The characteristics of the ODC mean that at higher 
values PO2 can drop for several minutes without any 
indication by pulse oximetry.  Then as PO2 
continues to drop to lower values pulse oximetry 
drops abruptly. 
The ODC varies from patient to patient depending 
on the values of different parameters (pH, T, PCO2, 
[DPG]) and these variations affect the position of 
the ODC but not the shape (Figure 3) [7].  The 
effect on position changes the PO2 at which the 
ODC plateau transitions to the sharp curve.  Thus 
patient-to-patient variability adds difficulty in 
determining at which PO2 a patient’s saturation will 
begin to decline rapidly. 
Patient variability and limitations to pulse 
oximetry make measuring saturation using existing 
methods difficult.  Maintaining sufficient levels of 
saturation is challenging because the response of a 
given individual to a particular oxygen flow rate is 
unpredictable.  The accuracy of pulse oximetry, 
which ranges from ±2% to 4%, limits its utility as 
an indicator of alveolar oxygen concentration [8].  
Because of this error combined with the nature of 
the ODC, high SpO2 could indicate a wide range of 
PO2, and give no indication as to how close to the 
steep portion of the curve a patient’s saturation is 
(Figure 4).  
If patient variability could be determined, and a 
patient specific ODC could be generated, the 
transition from plateau to sharp curve could be 
characterized and patient specific oxygen flow rates 
could be delivered and thus prevent saturation.  
Patient-specific model-based oxygen delivery could 
prevent hemoglobin desaturation while maintaining 
low enough oxygen levels for pulse oximetry to 
provide warning of respiratory depression.  One 
possibility for determining patient variability is to 
create a model which can use a subset of saturation 
values to fit a patient specific ODC.  We have 
developed such a model based on an oxygen 
delivery system we have developed and tested 
previously [9, 10].  
We have developed a model for characterizing 
patient specific variations in SpO2.  We have 
identified patient specific variations by 
characterizing a patient specific ODC.  Determining 
a patient specific curve relying solely on SpO2 
 
Figure 1: The oxyhemoglobin dissociation curve, a 
sigmoidal shaped curve which reaches a plateau and 
slowly approaches 100% saturation typically at a partial 
pressure of oxygen of 70 mmHg.  Below 70 mmHg the 
ODC has a sharp decline. 
 
Figure 2: The plateau of the ODC means for that portion 
of the relationship large changes in Po2 (ΔA) result in 
small changes in hemoglobin saturation while the sharp 
decline means that small changes in Po2 (ΔB) result in 
drastic changes in hemoglobin saturation. 
 
Figure 3: The ODC varies from patient to patient 
depending on the values of 4 parameters: concentration of 
the hydrogen ion (pH), temperature (T), partial pressure of 
carbon dioxide (PCO2), and concentration of 2,3-
diphosphoglycerate ([DPG]).  These variations affect the 
position of the ODC but not the shape.  The effect on the 
position changes the location of the transition from the 
ODC plateau to the sharp curve. 
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could add value to pulse oximetry and provide a 
non-invasive way to determine a patient’s curve. 
Our model predicts saturation by generating a 
patient-specific oxyhemoglobin dissociation curve.  
The model automatically adapts to patient    
variability.  Such a model could also help determine 
the minimum amount of oxygen necessary to 
maintain satisfactory oxygenation as considerable 
hyperoxia also has negative effects in some patients 
[11].  
The purpose of this study was to determine the 
effectiveness of our patient-specific model.  A 
model-based and patient specific approach to 
supplemental oxygen delivery could characterize 
patient variability and thus provide oxygen delivery 
specific to a patient’s needs [12].  This approach 
would provide the ability to keep a patient saturated 
sufficient enough to provide time for intervention 
while still reducing fire hazard.  
II. METHODS 
Study approval and risk determination came from 
the University of Utah Institutional Review Board.  
All volunteers and patients participated in this study 
with written informed consent. 
A. Theory 
The ODC is described using Hill’s equation: 
 
𝑆𝐻𝑏𝑂2 =  
(
𝑃𝑂2
𝑃50)
𝑛
1 + (
𝑃𝑂2
𝑃50)
𝑛 
 
Where P50 is the PO2 at which 50% of hemoglobin 
are saturated and where n is 2.7 in normal human 
blood.  The ODC can be linearized using natural 
logarithms as follows: 
 
𝑥 = 𝐿𝑛[𝑃𝑂2];  𝑦 = ln [
𝑆𝐻𝑏𝑂2
1 − 𝑆𝐻𝑏𝑂2
] 
 
We used this method to linearize the relationship 
between SpO2 and EtO2 for each participant.   
For each participant, the values of expected PAO2, 
measured SpO2, and measured expired oxygen 
concentration values were used to establish the 
framework for a specific ODC.  To establish a 
specific ODC, we fit a line to linearized data points 
and transformed that linear fit back into a patient 
specific ODC. 
B. Volunteer Study 
During the study, our prototype system delivered 
oxygen flows between 0 and 10 L/min.  Each flow 
rate and mode combination was delivered for two 
minutes.  At the end of each two-minute period, 
oxygen flow was turned off and the expired oxygen 
was sampled for three breaths. 
C. Clinical Study 
Supplemental oxygen was given using a nasal 
cannula throughout the procedure.  The protocol 
called to deliver varying flow rates from 0.4 L/min 
to 5 L/min.  Each flow rate was delivered for 2 
minutes.  At the end of each two-minute period, 
oxygen flow was turned off and the expired gas was 
analyzed using for 3 breaths.   
D. Model Validation 
We used model fit error techniques to show the 
ability of the model to fit volunteer and patient 
SpO2.  Fit results were generated by using the fitted 
patient specific curve shift to estimate oxygen 
concentrations.  Fit errors were used to assess the 
ability of the model to fit SpO2.   
To validate our model, we tested the ability of the 
volunteer developed model to fit data obtained in 
the volunteer study and clinical trial.  Model fit 
 
Figure 4: The accuracy of pulse oximetry, which ranges 
from ±2% to 4%, limits its utility as an indicator of 
alveolar oxygen concentration.  Because of this error band 
combined with the nature of the ODC, high SpO2 could 
indicate a wide range of PO2, and give no indication as to 
how close to the steep portion of the curve a patient’s 
saturation is. 
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values were compared with actual measurements for 
error analysis and absolute error was measured. 
III. RESULTS 
Figure 5 shows representative data from a clinical 
trial patient.  This data is an example of the ability 
of our model to adapt to the patient specific points.  
This model adaptation shows how, in this particular 
patient, oxygen saturation would begin to drop long 
before the standard ODC predicts.  In this patient, 
oxygen saturation reaches 98% at an end-tidal 
oxygen value of approximately 50% as compared to 
the standard curves estimate of a regular end-tidal 
concentration obtained when breathing room air of 
15%. 
 
A. Volunteer Study 
Thirty subjects (14 females/16 males; age: 34 ± 12 
years, height: 172.4 ± 10.1 cm, weight: 75 ± 17.6 
kg, mean ± SD) participated in this study.  All 
participants enrolled finished the study. 
For our volunteer study, the nominal average line 
is quite close to the standard curve (Figure 6).  The 
standard deviation appears to be larger to the right 
compared to the left, this is most likely due to the 
nature of the curve where values approach 100% 
saturation asymptotically. 
For both the whole data set and the average for 
each volunteer, the model adapted fit (red) showed 
great improvement over the standard curve fit 
(black).  The cumulative density plot of the model 
fit error for the entire data set in our volunteer study 
and the average for each volunteer had greater 
accuracy than the standard fit.  For the model 
adapted fit, 90% of data points had an error of less 
than 0.8% while for the standard fit 90% of data 
points had an error less than 2.0% (Figure 7).  The 
largest average fit error when using our model 
adapted fit was 0.3% while the largest average 
standard curve fit was 2.4% (Figure 8). 
 
Figure 5: Representative data from a clinical trial patient.  
This data is an example of the ability of our model to adapt 
to the patient specific points.  The model’s adaptation 
shows how in this particular patient oxygen saturation 
would begin to drop long before the standard ODC would 
predict. 
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Figure 6: Nominal curve and uncertainty for our volunteer 
study with 30 healthy volunteers.  The nominal average 
line (solid red) is quite close to the standard curve (solid 
black).  Individual patient curves are shown in gray.  The 
standard deviations shown show a good estimation of the 
variance in oxyhemoglobin dissociation curves between 
volunteers.  The standard deviation appears to be larger to 
the right compared to the left, this is most likely due to the 
nature of the curve where values approach 100% 
saturation asymptotically. 
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Figure 7: Cumulative density plot of the model fit error for 
the entire data set in our volunteer study.  The model 
adapted fit (red) shows great improvement over the 
standard curve fit (black).  This plot demonstrates the 
ability of our model to provide a more accurate estimate of 
healthy volunteer saturations when compared with the 
standard oxyhemoglobin dissociation curve.  For the 
model adapted fit, 90% of data points had an error of less 
than 0.8% while for the standard fit 90% of data points had 
an error less than 2.0%. 
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B. Clinical Study 
Sixty patients (32 females/28 males; age: 66.5 ± 
12.7, height: 170.3 ± 12.2 cm, weight: 81.2 ± 19.3 
kg, mean ± SD) participated in our trial and all 
patients completed the study.  All patients met 
eligibility criteria and were recruited between 
12/1/16 and 4/14/17. 
For our clinical study, the nominal average line is 
quite different than the standard curve (Figure 9).  
The standard deviations shown show a good 
estimation of the variance in oxyhemoglobin 
dissociation curves between volunteers.  This 
nominal curve is a good demonstration of the 
variability of the oxyhemoglobin dissociation curve 
from patient to patient and the difficulty of 
predicting patient saturation levels.  
For both the whole data set and the average for 
each patient, the model adapted fit (red) showed 
great improvement over the standard curve fit 
 
Figure 8: Cumulative density plot of the model fit error for 
our volunteer study using the average for each patient.  
The average model adapted fit (red) shows great 
improvement over the average standard curve fit (black).  
This plot demonstrates the ability of our model to provide 
a more accurate estimate of patient saturations when 
compared with the standard oxyhemoglobin dissociation 
curve.  The largest average fit error when using our model 
adapted fit was 0.3% while the largest average standard 
curve fit was 2.4%. 
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Figure 9: Nominal curve and uncertainty for our clinical 
study with 60 patients.  The nominal average line (solid 
red) is quite different than the standard curve (solid black).  
The standard deviations shown show a good estimation of 
the variance in oxyhemoglobin dissociation curves 
between volunteers.  This nominal curve is a good 
demonstration of the variability of the oxyhemoglobin 
dissociation curve from patient to patient and the difficulty 
of predicting patient saturation levels. 
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Figure 10: Cumulative density plot of the model fit error 
for the entire cohort in our clinical study.  The model 
adapted fit (red) shows great improvement over the 
standard curve fit (black).  This plot demonstrates the 
ability of our model to provide a more accurate estimate of 
patient saturations when compared with the standard 
oxyhemoglobin dissociation curve.  For the model adapted 
fit, 90% of data points had an error of 1.3% or less while 
for the standard fit 90% of data points had an error of 2.6% 
or less. 
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Figure 11: Cumulative density plot of the model fit error 
for our clinical study using the average for each patient.  
The average model adapted fit (red) shows great 
improvement over the average standard curve fit (black).  
This plot demonstrates the ability of our model to provide 
a more accurate estimate of patient saturations when 
compared with the standard oxyhemoglobin dissociation 
curve.  The largest average fit error when using our model 
adapted fit was 0.6% while the average standard curve fit 
error approached 5.4%. 
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 (black).  The cumulative density plot of the model 
fit error for the entire data set in our clinical study 
and the average for each patient both had greater 
accuracy than the standard fit.  For the model 
adapted fit, 90% of data points had an error of less 
than 1.3% while for the standard fit 90% of data 
points had an error less than 2.6% (Figure 10).  The 
largest average fit error when using our model 
adapted fit was 0.6% while the largest average 
standard curve fit was 5.4% (Figure 11).   
IV. DISCUSSION 
This study has shown that our model is able to fit 
patient saturation values with higher accuracy than 
when using the standard oxyhemoglobin 
dissociation curve.  We have also shown that the 
variability of the ODC from patient to patient is 
quite large, making predicting patient saturation 
quite difficult. 
Our results demonstrate the ability of our model 
to provide a more accurate estimate of healthy 
volunteer and patient saturations when compared 
with the standard oxyhemoglobin dissociation 
curve.  These accurate estimates could help 
determine a patient’s specific ODC and thus define  
where on the PO2 scale the patient’s SpO2 would 
start to drop drastically. 
We experienced large variations in the 
relationship between PO2 and SpO2 in both 
volunteers and patients.  The larger variation in the 
relationship in patients could be attributed to the 
fact that the patients underwent sedation and 
experienced lower minute volume.  The variation 
could also be attributed to the difference in age 
between the volunteers and patients.  This variation 
can be quite difficult to predict and our model 
shows an initial step toward understanding and 
predicting these differences. 
Although our model was able to fit patient data 
values within the range measured, we did 
experience unusual behavior beyond the ranges we 
tested.  The model results would at times cross over 
from the right side of the standard ODC to the left 
side or vice versa.  This behavior has not been 
experienced in clinical data and may be caused by a 
number of things including the ±2% error span of 
SpO2 measurements and noise. 
Future directions for this research include using a 
subset of patient data to create a model fit and 
subsequently using that model fit to predict 
remaining patient saturation values.  This type of 
technique would make acquiring the patient-specific 
ODC less cumbersome as only a small amount of 
sample points would be needed to characterize the 
curve. 
Once clinically validated, our model would 
increase the utility of pulse oximetry measurements 
when saturation is >98%.  Future validation would 
include predicting patient saturation for a range of 
levels of supplemental O2.   
A future use for this model would be to combine 
the model with other existing models to simulate 
and predict O2 saturation and time to apnea in 
patients with varying levels of respiratory drive. 
Predicting the course of SpO2 for a given amount of 
time could help explore and experiment with 
simulations on different clinical scenarios that may 
not be safe to study in volunteers or patients. 
 In summary, we have developed and tested a 
model for fitting the oxyhemoglobin dissociation 
curve to patients.  We have shown improved fit 
when compared to the standard ODC.  This model 
could potentially be used to predict time to 
desaturation specific to a patient. 
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